JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:145; doi:10.1136/jnnp.2005.079376
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, M J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, M J
Topic Collections
Right arrowRelevant Article

EDITORIAL COMMENTARY

Teratogenic effects of antiepileptic drugs

Major congenital malformations and antiepileptic drugs: prospective observations

M J Brodie

Epilepsy Unit, Western Infirmary, Glasgow, Scotland

Correspondence to:
Correspondence to:
M J Brodie
Director, Epilepsy Unit, Western Infirmary, Glasgow G11 6NT, Scotland; mjb2k@clinmed.gla.ac.uk


High dose lamotrigine may be teratogenic

Keywords: congenital malformations; pregnancy; antiepileptic drugs

The first 150 words of the full text of this article appear below.

The spectre of teratogenesis has been hanging over young women with epilepsy ever since the association of fetal malformations with antiepileptic drug (AED) exposure was first mooted by Roy Meadow in a letter to The Lancet in 1968.1 There followed a flood of retrospective reports and small prospective studies suggesting that perhaps all of the established drugs could be implicated in this problem. The global licensing of nine new antiepileptic drugs over the past 15 years has added to the confusion. Those agents that did not appear to be teratogenic in rodents have been touted by enthusiasts as "possibly" safe in pregnancy. The most confident claims were made for lamotrigine, and schedules have been devised to switch women of childbearing age from carbamazepine, phenytoin, or sodium valproate to this drug. What was (is) clearly needed was large prospective registries including only women in whom the . . . [Full text of this article]


Relevant Article

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register
J Morrow, A Russell, E Guthrie, L Parsons, I Robertson, R Waddell, B Irwin, R C McGivern, P J Morrison, and J Craig
J. Neurol. Neurosurg. Psychiatry 2006 77: 193-198. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.